These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33005991)

  • 21. ASO Author Reflections: The Peritoneum is an Active Immunological Compartment.
    Thorgersen EB; Flatmark K
    Ann Surg Oncol; 2021 Sep; 28(9):5263-5264. PubMed ID: 33939046
    [No Abstract]   [Full Text] [Related]  

  • 22. Incidence, prognosis, and treatment options for patients with synchronous peritoneal carcinomatosis and liver metastases from colorectal origin.
    Thomassen I; van Gestel YR; Lemmens VE; de Hingh IH
    Dis Colon Rectum; 2013 Dec; 56(12):1373-80. PubMed ID: 24201391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ASO Author Reflections: Toward Improved Selection of Patients for Cytoreduction and HIPEC: Identification of Prognostic Factors for Patients with Colorectal Peritoneal Metastases.
    Sluiter NR; Tuynman JB
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):840-841. PubMed ID: 30302638
    [No Abstract]   [Full Text] [Related]  

  • 24. Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study.
    Lemmens VE; Klaver YL; Verwaal VJ; Rutten HJ; Coebergh JW; de Hingh IH
    Int J Cancer; 2011 Jun; 128(11):2717-25. PubMed ID: 20715167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ASO Author Reflections: The Prognostic Value of Time to Metastasis in Colorectal Liver Metastasis.
    Höppener DJ; Verhoef C
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):798-799. PubMed ID: 31646452
    [No Abstract]   [Full Text] [Related]  

  • 26. Synchronous liver resection with cytoreductive surgery for the treatment of liver and peritoneal metastases from colon cancer: results from an Australian centre.
    Alzahrani N; Ung L; Valle SJ; Liauw W; Morris DL
    ANZ J Surg; 2017 Nov; 87(11):E167-E172. PubMed ID: 26178318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ASO Author Reflections: Potential Values of Peritoneal Cell-Free Tumor DNA Testing.
    Chan CHF
    Ann Surg Oncol; 2020 Dec; 27(13):5072-5073. PubMed ID: 33078317
    [No Abstract]   [Full Text] [Related]  

  • 28. ASO Author Reflections: Molecular Profiling Can Provide Personalized Clinical Guidance in the Management of Peritoneal Malignancies.
    Moaven O; Miller LD; Levine EA
    Ann Surg Oncol; 2020 Dec; 27(13):5024-5025. PubMed ID: 32749622
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of colorectal peritoneal metastases requires multidisciplinary efforts.
    Goéré D; Gelli M
    Lancet Oncol; 2016 Dec; 17(12):1630-1631. PubMed ID: 27743919
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical outcomes of complete cytoreduction with concurrent liver resection followed by hyperthermic intraperitoneal chemotherapy for synchronous peritoneal and liver metastatic colorectal cancer.
    Jeon Y; Park EJ; Lim JH; Baik SH
    World J Surg Oncol; 2019 Dec; 17(1):214. PubMed ID: 31829188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ASO Author Reflections: Recurrence Predictors in Mucinous Appendiceal Tumors.
    Baumgartner JM
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):763-764. PubMed ID: 30411269
    [No Abstract]   [Full Text] [Related]  

  • 32. Prognostic Significance of Peritoneal Metastasis in Stage IV Colorectal Cancer Patients With R0 Resection: A Multicenter, Retrospective Study.
    Arakawa K; Kawai K; Ishihara S; Hata K; Nozawa H; Oba K; Sugihara K; Watanabe T
    Dis Colon Rectum; 2017 Oct; 60(10):1041-1049. PubMed ID: 28891847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ASO Author Reflections: Real-World Incidence of Peritoneal Carcinomatosis After Colon Cancer Resection and Why It Matters.
    Choi AH; Senthil M
    Ann Surg Oncol; 2020 Dec; 27(13):4949. PubMed ID: 32627117
    [No Abstract]   [Full Text] [Related]  

  • 34. [Management of synchronous distant metastasis of colorectal cancer].
    Murono K; Ishihara S; Watanabe T
    Nihon Shokakibyo Gakkai Zasshi; 2017; 114(7):1209-1216. PubMed ID: 28679978
    [No Abstract]   [Full Text] [Related]  

  • 35. ASO Author Reflections: Improving Outcomes in Diffuse Malignant Peritoneal Mesothelioma: Challenges and Opportunities.
    Leinwand JC; Kluger MD
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):742-743. PubMed ID: 32239340
    [No Abstract]   [Full Text] [Related]  

  • 36. ASO Author Reflections: Cost Effectiveness of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
    Lee ZJ; Teo CCM
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):757-758. PubMed ID: 30374919
    [No Abstract]   [Full Text] [Related]  

  • 37. ASO Author Reflections: Prognostic Utility of Pre- and Postoperative Circulating Tumor DNA Liquid Biopsies in Patients with Peritoneal Metastases.
    Baumgartner JM; Riviere P; Kurzrock R
    Ann Surg Oncol; 2020 Sep; 27(9):3268-3269. PubMed ID: 32303875
    [No Abstract]   [Full Text] [Related]  

  • 38. Metastatic Profile of Colorectal Cancer: Interplay Between Primary Tumor Location and KRAS Status.
    Zihui Yong Z; Ching GTH; Ching MTC
    J Surg Res; 2020 Feb; 246():325-334. PubMed ID: 30737098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ASO Author Reflections: Partial versus Total Cystectomy in Bladder-Involving Colorectal Cancer.
    Yoshida T; Shida D
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):686-687. PubMed ID: 31399818
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.